IABC - International Association of Business CommunicatorsBe Heard HomeJoin IABCSite MapContact Us
 


publications

CW Bulletin

CW Bulletin is the e-newsletter supplement to CW magazine. Sent each month to all members, every issue of CW Bulletin presents articles, case studies and additional resources on timely topics in communication.

top.gif CW Bulletin


Vancouver Regional Health Authority Opens North America’s First Supervised Injection Site

By Clay Adams, ABC


On 21 September 2003, the doors opened to North America’s first Supervised Injection Site (SIS) Scientific Research Pilot in Vancouver, British Columbia, Canada. A supervised injection site (SIS) is a safe, clean facility where users inject drugs under supervision of clinical staff. Users must bring their own drugs (none are supplied) and inject themselves (clinical staff on hand are there to supervise, not guide or assist). By injecting in a clean, safe location there is reduced risk of infection through second-hand needles or contaminated water, and staff can provide medical support in the event of an overdose incident. Access to counseling and rehab treatment are also available.

Vancouver Coastal Health (VCH), one of five regional health authorities in the Canadian province of British Columbia, operates the North American site, which is located in Vancouver’s Downtown Eastside (DTES). The Downtown Eastside is a neighborhood plagued by poverty, homelessness, prostitution and crime—all of which contribute to a relatively high rate of injection drug use and, associated with it, infectious disease.

In the City of Vancouver, there are approximately 8,000 intravenous drug users. More than 50 percent of these are located in the Downtown Eastside. It is a problem that impacts not just those who are injecting the drugs, but also results in huge financial costs for the larger health system. According to the BC Centre for Disease Control, 30-40 percent of injection drug users in the Downtown Eastside have HIV and more than 90 percent have hepatitis C. The cost for treating these conditions is estimated at CDN$150,000 per person, or more than CDN$700 million, excluding additional costs for emergency medical intervention for overdoses, infections, wounds, etc.

In March 2003, VCH submitted an application to create an SIS under new guidelines issued by the federal department of health. VCH’s media relations team focused on one particular reporter at Vancouver’s leading and best-read daily newspaper, The Vancouver Sun. This reporter has a reputation for accurate reporting on drug use, Vancouver’s DTES and other injection sites worldwide. With an average daily circulation of 512,000 and a target readership of educated men and women between 35-64 years old, the Sun was a key tool in reaching the wider public with key messages. VCH also worked closely with the local Chinese media, given its interest in the SIS from the neighboring Chinatown business community.

Through the execution of a carefully planned media launch, VCH achieved impressive results. When the Vancouver SIS opened its doors, site use numbers in the first eight hours of operation were almost 10 times those of the comparable Australian site, Kings Cross. On the first full day of operation, the numbers were 114, as compared to 12 visitors in the first 24-hour period at Kings Cross. Since then, VCH’s numbers have continued to climb. After one month of operation, the site was experiencing an average of 250 injections per day, compared to the Australian site where, after one month of operation, the total number of injections was 496. The Vancouver site is now averaging around 550 injections per day, with heroin and cocaine being the drugs of choice.

As the nine-month milestone for North America’s first legal supervised injection site approaches, VCH continues to attract significant interest. Media calls are constant, mainly seeking to explore whether or not the site is making a positive impact on the health of injection drug users and the safety of the surrounding community. Over the next two and a half years, evaluators will examine the project to determine if the scientific data supports the value of such a concept.

Support appears to be growing in the community. Some Chinatown business leaders have been quoted in local media as claiming the number of needles on city streets appears to be declining, and that there is now less visible drug injecting taking place in public areas.

While the jury is still out on the effectiveness of the Vancouver SIS in reducing drug use and crime and improving the health of drug users, other Canadian cities (Victoria, Toronto and Montreal) are reportedly looking at establishing similar sites in an effort to address the health issues associated with illegal drug use in their jurisdictions.

 

Clay Adams, ABC is Director of Issues Management at Vancouver Coastal Health, British Columbia, Canada.